Substance evaluation - CoRAP

Substance evaluation - CoRAP

Substance evaluation - CoRAP

If a substance is on this list, it means that a Member State has evaluated or will evaluate it over the coming years. The list is called the Community rolling action plan (CoRAP).

For each substance, the table shows the evaluating Member State, the (planned) year of evaluation and a short description of the concern which led to it being placed on the list.

Documents to do with substance evaluation are also available here. They include: documents justifying selection of the substances, decisions to request more information.  Member States' conclusions and Member States' final evaluation reports are included for substances for which evaluation has been finalised.

 

Notes to the Substance Evaluation table
  • Where two Members States are indicated, this is a joint evaluation. The first Member State mentioned leads the Evaluation and is the responsible competent authority in the meaning of Article 45(2) of REACH.
  • The substance public name is used. In most of the cases it is the name as disseminated on the ECHA website.
  • When the EC Number is not available, the number assigned to substance by ECHA after the inquiry process is used.
  • When the substances are included in the CoRAP, they have not yet been evaluated and thus the concern is indicative and not exhaustive or conclusive.
  • Contact details of the evaluating Member States are provided for all the substance included.
  • Please note that the justification document explains the grounds of the initial concerns that triggered the inclusion of the substance in the CoRAP for further clarification under substance evaluation. The justification document is based on a preliminary screening of the substance and is without prejudice to the outcome of the substance evaluation.

Legend:

Suspected PBT/vPvB: Potentially Persistent, Bioaccumulative and Toxic/very Persistent and very Bioaccumulative.
Suspected PMT/vPvM: Potentially Persistent, Mobile and Toxic/very Persistent and very Mobile.
CMR: generic term for known carcinogenic and/or mutagenic and/or reprotoxic properties (according to CLP harmonised or registrant self-classification or CLP Inventory). The concern can refer to C, M, R or a combination of those.
Suspected CMR: generic term for suspected carcinogenic and/or mutagenic and/or reprotoxic properties (not classified according to CLP harmonised or registrant self-classification). The concern can refer to (suspected) C, M, R or a combination of those.
Sensitiser: generic term for known sensitising properties (according to CLP harmonised or registrant self-classification or CLP Inventory).
Suspected sensitiser: generic term for suspected sensitising properties (not classified according to CLP harmonised or registrant self-classification).
RCR: Risk Characterisation Ratio 

Last updated 15 April 2024. Database contains 402 unique substances/entries.
Filter the list
Initial grounds for concern:

The List does not contain any Substances.
 
219-207-4
2386-87-0
2013
Ireland
Suspected CMR
Sensitiser
Exposure of workers
High RCR
Concluded
Details
700-403-8
-
2013
Belgium
Suspected PBT/vPvB
Consumer use
Wide dispersive use
Concluded
Details
204-337-6
119-61-9
2013
Denmark
Suspected CMR
Consumer use
High RCR
Wide dispersive use
Concluded
Details
205-736-8
149-30-4
2013
Germany
CMR
Sensitiser
Consumer use
Exposure of sensitive populations
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
231-150-7
7440-41-7
2013
Germany
Other exposure/risk based concern
Concluded
Details
202-163-5
92-52-4
2013
Portugal
Suspected PBT/vPvB
High (aggregated) tonnage
Concluded
Details
254-052-6
38640-62-9
2013
Sweden
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Follow-up
Details
202-496-6
96-29-7
2013
Germany
CMR
Sensitiser
Consumer use
Cumulative exposure
High RCR
Wide dispersive use
Concluded
Details
205-480-7
141-32-2
2013
Sweden
Suspected CMR
High (aggregated) tonnage
Other exposure/risk based concern
Concluded
Details
200-843-6
75-15-0
2013
France
CMR
Potential endocrine disruptor
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Concluded
Details
205-016-3
131-17-9
2013
Spain
CMR
Consumer use
Wide dispersive use
Concluded
Details
249-044-4
28472-97-1
2013
Italy
Suspected PBT/vPvB
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
247-660-8
26401-35-4
2013
Spain
Suspected PBT/vPvB
High (aggregated) tonnage
Other exposure/risk based concern
Wide dispersive use
Concluded
Details
200-001-8
50-00-0
2013
France
CMR
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
202-626-1
98-00-0
2013
Poland
CMR
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
203-492-7
107-46-0
2013
Norway
Suspected CMR
Consumer use
High (aggregated) tonnage
Information requested
Details
203-571-6
108-31-6
2013
Austria
Sensitiser
High (aggregated) tonnage
High RCR
Concluded
Details
203-624-3
108-87-2
2013
Finland
Suspected PBT/vPvB
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
448-020-2
-
2013
Slovakia
CMR
Suspected PBT/vPvB
High RCR
Concluded
Details
700-427-9
-
2013
Belgium
Suspected PBT/vPvB
Consumer use
Wide dispersive use
Concluded
Details
225-625-8
4979-32-2
2013
Germany
Suspected CMR
Suspected PBT/vPvB
Sensitiser
Consumer use
Exposure of workers
Wide dispersive use
Concluded
Details
217-421-2
1843-05-6
2013
Italy
Potential endocrine disruptor
Sensitiser
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
701-251-5
-
2013
Netherlands
CMR
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
700-161-3
-
2013
Netherlands
Suspected PBT/vPvB
Ongoing
Details
931-384-6
-
2013
Slovenia
Suspected PBT/vPvB
Consumer use
High (aggregated) tonnage
Concluded
Details
203-570-0
108-30-5
2013
Austria
Suspected CMR
Sensitiser
High (aggregated) tonnage
High RCR
Concluded
Details
210-382-2
614-45-9
2013
Italy
Sensitiser
Consumer use
Wide dispersive use
Concluded
Details
204-825-9
127-18-4
2013
Latvia
CMR
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
203-726-8
109-99-9
2013
Germany
CMR
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
214-685-0
1185-55-3
2013
Sweden
Sensitiser
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
220-449-8
2768-02-7
2013
Sweden
Suspected Sensitiser
Exposure of sensitive populations
Exposure of workers
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
202-908-4
101-02-0
2013
United Kingdom
Suspected CMR
Potential endocrine disruptor
Sensitiser
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
701-028-2
-
2013
France
Suspected PBT/vPvB
Consumer use
Exposure of sensitive populations
High (aggregated) tonnage
High RCR
Wide dispersive use
Ongoing
Details
231-944-3
7779-90-0
2013
Romania
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
242-060-2
18172-67-3
2014
Greece
Sensitiser
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
213-668-5
999-97-3
2014
Spain
High (aggregated) tonnage
High RCR
Concluded
Details
701-339-3
-
2014
Denmark
Suspected CMR
High (aggregated) tonnage
Other exposure/risk based concern
Concluded
Details
700-989-5
-
2014
Denmark
Suspected CMR
High (aggregated) tonnage
Other exposure/risk based concern
Concluded
Details
271-089-3
68515-47-9
2014
Denmark
Suspected CMR
High (aggregated) tonnage
Other exposure/risk based concern
Concluded
Details
271-085-1
68515-43-5
2014
Denmark
Suspected CMR
High (aggregated) tonnage
Other exposure/risk based concern
Concluded
Details
203-049-8
102-71-6
2014
United Kingdom
Suspected CMR
Suspected Sensitiser
Other hazard based concern
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
204-279-1
118-82-1
2014
Austria
Suspected CMR
Potential endocrine disruptor
Suspected PBT/vPvB
Suspected Sensitiser
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Follow-up
Details
201-222-2
79-74-3
2014
Italy
Suspected PBT/vPvB
High RCR
Information requested
Details
205-483-3
141-43-5
2014
United Kingdom
Suspected Sensitiser
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
239-701-3
15625-89-5
2014
France
Sensitiser
Exposure of workers
High RCR
Wide dispersive use
Concluded
Details
203-234-3
104-76-7
2014
Poland
Suspected CMR
Consumer use
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
212-782-2
868-77-9
2014
France
Suspected CMR
Sensitiser
Consumer use
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
203-680-9
109-55-7
2014
Austria
Sensitiser
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
428-970-4
13595-25-0
2014
Belgium
Suspected PBT/vPvB
Other hazard based concern
Consumer use
Exposure of environment
Concluded
Details
201-250-5
80-09-1
2014
Belgium
Suspected CMR
Potential endocrine disruptor
High (aggregated) tonnage
Concluded
Details
202-804-9
99-96-7
2014
Czech Republic
Suspected CMR
Potential endocrine disruptor
Consumer use
High (aggregated) tonnage
Concluded
Details
202-679-0
98-54-4
2014
Germany
Potential endocrine disruptor
High (aggregated) tonnage
Concluded
Details
284-660-7
84961-70-6
2014
Italy
Suspected PBT/vPvB
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
203-450-8
106-99-0
2014
Germany
CMR
Other exposure/risk based concern
Concluded
Details
700-992-1
-
2014
Norway
Suspected PBT/vPvB
Consumer use
High (aggregated) tonnage
Wide dispersive use
Follow-up
Details
253-775-4
38083-17-9
2014
Belgium
Suspected CMR
Consumer use
Wide dispersive use
Conclusion under preparation
Details
229-782-3
6731-36-8
2014
Germany
Suspected PBT/vPvB
Information requested
Details
200-901-0
75-78-5
2014
Czech Republic
Suspected PBT/vPvB
High (aggregated) tonnage
Concluded
Details
201-550-6
84-66-2
2014
Germany
CMR
Potential endocrine disruptor
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
210-871-0
624-92-0
2014
Germany
Exposure of environment
High (aggregated) tonnage
Other exposure/risk based concern
Concluded
Details
214-277-2
1119-40-0
2014
Poland
Potential endocrine disruptor
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
231-673-0
7681-57-4
2014
Hungary
Suspected CMR
Exposure of environment
Exposure of sensitive populations
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
248-948-6
28299-41-4
2014
Netherlands
Suspected PBT/vPvB
High (aggregated) tonnage
Information requested
Details
287-401-6
85507-79-5
2014
Denmark
Suspected CMR
High (aggregated) tonnage
Other exposure/risk based concern
Concluded
Details
206-354-4
330-54-1
2014
Finland
Potential endocrine disruptor
Other exposure/risk based concern
Wide dispersive use
Conclusion under preparation
Details
202-597-5
97-63-2
2014
Italy
Suspected CMR
Sensitiser
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
931-274-8
-
2014
Slovenia
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
931-745-8
-
2014
Sweden
Suspected PBT/vPvB
Exposure of environment
High RCR
Follow-up
Details
IRGANOX L 118
404-800-4
118832-72-7
2014
Germany
Suspected PBT/vPvB
Concluded
Details
248-666-3
27813-02-1
2014
France
Suspected CMR
Sensitiser
Consumer use
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
202-785-7
99-76-3
2014
France
CMR
Potential endocrine disruptor
Consumer use
Exposure of sensitive populations
High (aggregated) tonnage
Wide dispersive use
Follow-up
Details
201-297-1
80-62-6
2014
France
Sensitiser
Consumer use
Exposure of sensitive populations
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
205-201-9
135-57-9
2014
Belgium
Suspected PBT/vPvB
Exposure of environment
Concluded
Details
205-031-5
131-57-7
2014
Denmark
Potential endocrine disruptor
Cumulative exposure
Exposure of environment
Exposure of sensitive populations
Exposure of workers
Wide dispersive use
Ongoing
Details
201-280-9
80-46-6
2014
Germany
Potential endocrine disruptor
Consumer use
Wide dispersive use
Concluded
Details
284-325-5
84852-15-3
2014
Spain
Suspected PBT/vPvB
Consumer use
High (aggregated) tonnage
Wide dispersive use
Conclusion under preparation
Details
262-975-0
61788-44-1
2014
Germany
Potential endocrine disruptor
Suspected PBT/vPvB
Cumulative exposure
Concluded
Details
X4261
401-850-9
255881-94-8
2014
Belgium
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Concluded
Details
447-780-2
-
2014
Estonia
Suspected CMR
Suspected PBT/vPvB
Exposure of environment
Exposure of workers
Concluded
Details
231-131-3
7440-22-4
2014
Netherlands
Other hazard based concern
High (aggregated) tonnage
Other exposure/risk based concern
Wide dispersive use
Concluded
Details
216-653-1
1634-04-4
2014
France
Potential endocrine disruptor
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
205-286-2
137-26-8
2014
Sweden
Potential endocrine disruptor
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
809-930-9
1330-78-5
2014
Netherlands
Suspected PBT/vPvB
Other hazard based concern
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
246-677-8
25155-23-1
2014
Italy
Suspected PBT/vPvB
Exposure of environment
Exposure of workers
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
206-022-9
288-88-0
2015
Belgium
Suspected CMR
Other hazard based concern
Exposure of environment
High (aggregated) tonnage
Other exposure/risk based concern
Wide dispersive use
Concluded
Details
219-514-3
2451-62-9
2015
Poland
CMR
Suspected PBT/vPvB
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Concluded
Details
627-083-1
244235-47-0
2015
Spain
Suspected PBT/vPvB
High (aggregated) tonnage
Concluded
Details
274-581-6
70356-09-1
2015
Germany
Suspected PBT/vPvB
Consumer use
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
216-823-5
1675-54-3
2015
Denmark
Suspected CMR
Potential endocrine disruptor
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
229-962-1
6864-37-5
2015
Germany
Potential endocrine disruptor
Concluded
Details
203-872-2
111-46-6
2015
Hungary
Suspected CMR
Other hazard based concern
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
201-236-9
79-94-7
2015
Denmark
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
247-979-2
26761-45-5
2015
Denmark
Suspected CMR
Suspected Sensitiser
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
260-828-5
57583-34-3
2015
Netherlands
CMR
High (aggregated) tonnage
Suspended
Details
203-079-1
103-09-3
2015
Belgium
Suspected CMR
Consumer use
Wide dispersive use
Concluded
Details
204-442-7
121-00-6
2015
France
Suspected Reprotoxic
Potential endocrine disruptor
Consumer use
Exposure of sensitive populations
Wide dispersive use
Conclusion under preparation
Details
219-785-8
2530-85-0
2015
Ireland
Suspected Sensitiser
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
202-525-2
96-69-5
2015
Austria
Suspected CMR
Potential endocrine disruptor
Suspected PBT/vPvB
Sensitiser
Consumer use
Wide dispersive use
Information requested
Details
246-678-3
25155-25-3
2015
Netherlands
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Follow-up
Details
231-208-1
7446-70-0
2015
France
Suspected CMR
Exposure of workers
High (aggregated) tonnage
High RCR
Follow-up
Details

Export search results to: